2009
DOI: 10.1074/jbc.m109.020701 View full text |Buy / Rent full text
|
|

Abstract: Schistosomiasis is a parasitic disease affecting over 200 million people currently treated with one drug, praziquantel. A possible drug target is the seleno-protein thioredoxin-glutathione reductase (TGR), a key enzyme in the pathway of the parasite for detoxification of reactive oxygen species. The enzyme is a unique fusion of a glutaredoxin domain with a thioredoxin reductase domain, which contains a selenocysteine (Sec) as the penultimate amino acid. Auranofin (AF), a gold-containing compound already in cli… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
9
201
1

Publication Types

Select...

Relationship

0
0

Authors

Journals